Als er een industrie die sneaky controle over zoveel mogelijk mensen probeert te krijgen is het wel de tabaksindustrie! De ingredienten van sigfaretten zijn geheim, maar steeds meer wordt ontrafelt hoe ze werken. Chemische stoffen worden toegevoegd voor extra verslavende werking en snellere werking.
Decennia heeft de tabaksindustrie geprobeerd de nieuwsgeving erover te verhinderen en te manipuleren. Zie onderstaand bericht over de geheime memo's die uitgeklekt zijn.
De overheid heeft een interessante rol hierbij. Enerzijds ontvangen zij veel accijns. Een aanzienlijk deel van het budget komt van sigaretten en die accijns worden steeds meer verhoogd. Eigenlijk wel raar want uiteindelijk ontmoedigd het waarschijnlijk (jonge) rokers. En op die manier snijden ze zichzelf in de vingers.
En waarom dan het rookverbod? Een druppel op de gloeiende plaat? Want waarom verbieden ze het niet in zijn geheel?
Ik probeer niet meer afhankelijk te zijn van de tabaksindustrie en de financiering van miljardenindustrien door te stoppen met roken. Maar t is niet makkelijk.
Zijn er tin foil hatters die hen nog wel steunen? En wat zijn jullie gedachten over deze industrie?
Bron: http://www.ash.org/pr/951201.html
Decennia heeft de tabaksindustrie geprobeerd de nieuwsgeving erover te verhinderen en te manipuleren. Zie onderstaand bericht over de geheime memo's die uitgeklekt zijn.
De overheid heeft een interessante rol hierbij. Enerzijds ontvangen zij veel accijns. Een aanzienlijk deel van het budget komt van sigaretten en die accijns worden steeds meer verhoogd. Eigenlijk wel raar want uiteindelijk ontmoedigd het waarschijnlijk (jonge) rokers. En op die manier snijden ze zichzelf in de vingers.
En waarom dan het rookverbod? Een druppel op de gloeiende plaat? Want waarom verbieden ze het niet in zijn geheel?
Ik probeer niet meer afhankelijk te zijn van de tabaksindustrie en de financiering van miljardenindustrien door te stoppen met roken. Maar t is niet makkelijk.
Zijn er tin foil hatters die hen nog wel steunen? En wat zijn jullie gedachten over deze industrie?
Bron: http://www.ash.org/pr/951201.html
THE NEWEST SECRET TOBACCO-INDUSTRY MEMO
Still another previously secret tobacco industry memo has been made public.
This one says that cigarettes are simply another "nicotine delivery system" like the nicotine patches and chewing gum which are regulated by the FDA.
It also says that nicotine is just like cocaine and morphine.
Here are two ASH press releases about the document and the company's statement regarding its release, excerpts from the article about its release in the Wall Street Journal, and excerpts from the memo itself.
--------------------------------------------------------------------------------
ASH PRESS RELEASE: FRIDAY, DECEMBER 8, 1995
CONFIDENTIAL PHILIP MORRIS MEMO SAYS NICOTINE IS LIKE COCAINE AND MORPHINE
ASH FILING IT WITH FDA AS EVIDENCE IN CIGARETTE REGULATION PROCEEDING
A recent confidential Philip Morris [PM] memo likens nicotine to cocaine and morphine; admits that "the primary reason" people smoke is "to deliver nicotine into their bodies"; and says that smokers use nicotine to "change psychological states."
These admissions directly contradict testimony given under oath by the then head of PM's tobacco division, William Campbell, who swore that "nicotine contributes to the taste of cigarettes and the pleasures of smoking."
Campbell also testified that "the presence of nicotine does not make cigarettes a drug or smoking an addiction."
However, the PM memo says that cigarettes are simply "nicotine delivery systems" like nicotine "chewing gum, patches, aerosol sprays, and inhalers." Nicotine in all of these forms have always been regarded as a "drug," and subject to regulation as a drug by the Food of Drug Administration [FDA].
Indeed, a central premise the FDA must establish before it can go ahead with its proposal to regulate cigarettes is to establish that nicotine is a drug, and that manufacturers were aware of its drug-like effects.
For this reason a national antismoking organization, Action on Smoking and Health (ASH), says it will file a copy of the confidential memo with the FDA as evidence in the agency's ongoing proceeding aimed at regulating the sale, promotion, and advertising of cigarettes to teens and pre-teens.
The FDA's proposed rule is based upon a legal principle established in a law suit filed by ASH, says law professor John Banzhaf, ASH's Executive Director.
In addition, in its own law suit filed against the FDA for proposing to regulate cigarettes, the six major tobacco companies charge that ASH's "threats," "pressure," and "a carefully orchestrated public relations campaign" were behind the agency's action.
"This new memo, even more than other tobacco documents previously revealed, is likely to convict the tobacco industry in the courts, as well as in the courts of public opinion," says Banzhaf.
--------------------------------------------------------------------------------
ASH PRESS RELEASE: FRIDAY, DECEMBER 8, 1995
PHILIP MORRIS ADMITS NICOTINE MEETS LEGAL TEST OF "DRUG"
SAYS PEOPLE SMOKE PRIMARILY FOR PHARMACOLOGICAL EFFECTS OF NICOTINE
In its statement responding to today's article in the Wall Street Journal about a memo conceding that cigarettes are simply "nicotine delivery systems" like patches and chewing gum, Philip Morris [PM] admits that nicotine meets the legal definition of a "drug" necessary for regulation by the FDA.
While PM's release stresses that nicotine's "pharmacological effects" don't necessarily mean that it is addictive, addiction is not a requirement for FDA jurisdiction, as well as non-prescription drugs regulated by the FDA aren't addictive.
By law any substance other than a food which is intended to "affect the structure or any function of the body of man" þ in other words, to produce pharmacological effects þ is a "drug" subject to FDA jurisdiction.
The release also admits that "Philip Morris employees have . . . stated that people smoke primarily for the pharmacological effects of nicotine."
Thus, in addition to the key admission that nicotine creates pharmacological effects in smokers, the tobacco giant also conceded that such effect are a primary reason why people smoke.
This, the U.S. Court of Appeals held in a law suit brought by Action on Smoking and Health (ASH), may by itself satisfy the requirements for the classification of a substance as a "drug."
The PM release argues that such pharmacological effects, by themselves, shouldn't make substances subject to FDA jurisdiction, citing the pharmacological effects of caffeine and sugar.
But, says Banzhaf, caffeine is a "drug" when it is sold in tablets.
Moreover, caffeine þ like sugar þ is already within the jurisdiction of the FDA when it is found in foods, either naturally as in the case of coffee or tea, or when added as an additional ingredient to foods such as soft drinks.
Banzhaf also noted that the legal test for a "drug" depends upon the intent of the manufacturer's executives, not obscure chemists who work for them.
--------------------------------------------------------------------------------
EXCERPTS FROM FREEDMAN, TOBACCO: PHILIP MORRIS MEMO LIKENS NICOTINE TO COCAINE, WALL STREET JOURNAL, DEC. 8, 1995
Tobacco-company executives have long maintained that people smoke because they enjoy the taste and sensation. The industry publicly rejects the allegation that cigarettes function primarily as nicotine dispensers. But with unprecedented bluntness, an internal Philip Morris Cos. draft report freely acknowledges what critics have charged: Cigarettes are a "nicotine delivery system"; the main reason people smoke is to get nicotine into their bodies; and nicotine is chemically "similar" to such drugs as cocaine. The confidential internal document, which is undated but cites data from as recently as 1992, is a proposal for a "safer" cigarette with the code name Table. Steven Parrish, Philip Morris's top spokesman, says the document was written by a nonscientist and doesn't reflect the views of the company on nicotine or smoking. An individual at the company further explains that the task force working on Project Table disbanded in late 1992 after making a presentation to senior management.
In congressional testimony and other public statements, top cigarette-company executives have denied the FDA's allegation about cigarettes' chief purpose. The Philip Morris document, however, appears to lend some support to the claim by asserting that "the primary reason" people smoke is "to deliver nicotine into their bodies."
The 15-page Philip Morris draft report likens nicotine to a drug in both its composition and its effects on the brain. In calling nicotine a "similar, organic chemical" to the drugs cocaine, morphine, quinine and atropine, the document states that "while each of these substances can be used to affect human physiology, nicotine has a particularly broad range of influence."
Nicotine travels to the brain about eight to 10 seconds after a smoker inhales and "alters the state of the smoker," according to the Philip Morris draft report. Nicotine does this, it says, by becoming both a neurotransmitter, a chemical substance that transmits signals from one nerve cell to another, and a stimulant. "Nicotine mimics the body's most crucial neurotransmitter, acetycholine (ACH), which controls heart rate and message sending within the brain," the draft report states.
In this way, the document continues, "nicotine is used to change psychological states leading to enhanced mental performance and relaxation." The draft report adds that "a little nicotine seems to stimulate, while a lot sedates a person. A smoker learns to control the delivery of nicotine through the smoking technique to create the desired mood state."
Mr. Parrish, the Philip Morris spokesman, responds, "We have acknowledged in public documents that nicotine, like many, many other things, has pharmacological effects, but that doesn't mean that cigarette smoking is addictive." He adds, "This document nowhere says that nicotine produces addiction -- the document doesn't even discuss addiction."
Cigarette-company executives have described the role of nicotine much differently than does the Philip Morris document. Last April, for instance, William Campbell, then head of Philip Morris's tobacco unit, testified at a congressional hearing that "nicotine contributes to the taste of cigarettes and the pleasures of smoking. The presence of nicotine, however, does not make cigarettes a drug or smoking an addiction." The document describes Philip Morris's own proposed entry as a "nicotine delivery device." And it lumps cigarettes with products that have no other function than to dispense nicotine: "Nicotine delivery devices range from snuff, chewing tobacco, cigars, pipes and conventional cigarettes to unique smoking articles, chewing gum, patches, aerosol sprays and inhalers." This statement is potentially useful to the FDA in its effort to prove that tobacco companies are in the drug business, health officials say.
--------------------------------------------------------------------------------
EXCERPTS FROM THE MEMO ITSELF
Different people smoke for different reasons. But the primary reason is to deliver nicotine into their bodies. Nicotine is an alkaloid derived from the tobacco plant. It is a physiologically active, nitrogen containing substance. Similar organic chemicals include nicotine, quinine, cocaine, atropine and morphine. While each of these substances can be used to affect human physiology, nicotine has a particularly broad range of influence.
During the smoking act, nicotine is inhaled into the lungs in smoke, enters the bloodstream and travels to the brain in about eight to ten seconds. The nicotine alters the state of the smoker by becoming a neurotransmitter and a stimulant. Nicotine mimics the body's most important neurotransmitter, acetycholine (ACH), which controls heart rate and message sending within the brain. The nicotine is used to change physiological states leading to enhanced mental performance and relaxation. A little nicotine seems to stimulate, while a lot sedates a person. A smoker learns to control the delivery of nicotine through the smoking technique to create the desired mood state. In general, the smoker uses nicotine's control to moderate a mood, arousing attention in boring situations and calming anxiety in tense situations. Smoking enhances the smoker's mental performance and reduces anxiety in a sensorially pleasurable form.
In its broadest sense, the cigarette is a pleasure product. It alters mood states just like the caffeine, alcohol and sugar in other Philip Morris products that affect human physiology and psychology. As with nicotine, these substances become part of an individual's life style and are used as coping mechanisms to help adjust to the environment.
Nicotine delivery devices range from snuff, chewing tobacco, cigars, pipes and conventional cigarettes to unique smoking articles, chewing gum, patches, aerosol sprays and inhalers. The manufacturers of these products also vary considerably in type, size, areas of expertise and marketing approach. The chart below summarizes the major competitors, their area of focus and their target market.
The pharmaceutical companies, on the other hand, are pursuing substitute nicotine delivery devices in a range of formats -- from patches to pills to inhalers. Their stated motivation is smoking cessation. The drug company devices generally lack the ritual of the smoking act and its sensual pleasures, but they do deliver nicotine in its most basic form.
Philip Morris has chosen to pursue a nicotine delivery device that, like RJR's Premier, continues the cigarette tradition of sucking on a cylindrical mouthpiece to inhale flavorings and nicotine form a tobacco based product.
NOTE: The entire document may be downloaded from the Wall Street Journal's Money & Investing Update at:
http://update.wsj.com
Still another previously secret tobacco industry memo has been made public.
This one says that cigarettes are simply another "nicotine delivery system" like the nicotine patches and chewing gum which are regulated by the FDA.
It also says that nicotine is just like cocaine and morphine.
Here are two ASH press releases about the document and the company's statement regarding its release, excerpts from the article about its release in the Wall Street Journal, and excerpts from the memo itself.
--------------------------------------------------------------------------------
ASH PRESS RELEASE: FRIDAY, DECEMBER 8, 1995
CONFIDENTIAL PHILIP MORRIS MEMO SAYS NICOTINE IS LIKE COCAINE AND MORPHINE
ASH FILING IT WITH FDA AS EVIDENCE IN CIGARETTE REGULATION PROCEEDING
A recent confidential Philip Morris [PM] memo likens nicotine to cocaine and morphine; admits that "the primary reason" people smoke is "to deliver nicotine into their bodies"; and says that smokers use nicotine to "change psychological states."
These admissions directly contradict testimony given under oath by the then head of PM's tobacco division, William Campbell, who swore that "nicotine contributes to the taste of cigarettes and the pleasures of smoking."
Campbell also testified that "the presence of nicotine does not make cigarettes a drug or smoking an addiction."
However, the PM memo says that cigarettes are simply "nicotine delivery systems" like nicotine "chewing gum, patches, aerosol sprays, and inhalers." Nicotine in all of these forms have always been regarded as a "drug," and subject to regulation as a drug by the Food of Drug Administration [FDA].
Indeed, a central premise the FDA must establish before it can go ahead with its proposal to regulate cigarettes is to establish that nicotine is a drug, and that manufacturers were aware of its drug-like effects.
For this reason a national antismoking organization, Action on Smoking and Health (ASH), says it will file a copy of the confidential memo with the FDA as evidence in the agency's ongoing proceeding aimed at regulating the sale, promotion, and advertising of cigarettes to teens and pre-teens.
The FDA's proposed rule is based upon a legal principle established in a law suit filed by ASH, says law professor John Banzhaf, ASH's Executive Director.
In addition, in its own law suit filed against the FDA for proposing to regulate cigarettes, the six major tobacco companies charge that ASH's "threats," "pressure," and "a carefully orchestrated public relations campaign" were behind the agency's action.
"This new memo, even more than other tobacco documents previously revealed, is likely to convict the tobacco industry in the courts, as well as in the courts of public opinion," says Banzhaf.
--------------------------------------------------------------------------------
ASH PRESS RELEASE: FRIDAY, DECEMBER 8, 1995
PHILIP MORRIS ADMITS NICOTINE MEETS LEGAL TEST OF "DRUG"
SAYS PEOPLE SMOKE PRIMARILY FOR PHARMACOLOGICAL EFFECTS OF NICOTINE
In its statement responding to today's article in the Wall Street Journal about a memo conceding that cigarettes are simply "nicotine delivery systems" like patches and chewing gum, Philip Morris [PM] admits that nicotine meets the legal definition of a "drug" necessary for regulation by the FDA.
While PM's release stresses that nicotine's "pharmacological effects" don't necessarily mean that it is addictive, addiction is not a requirement for FDA jurisdiction, as well as non-prescription drugs regulated by the FDA aren't addictive.
By law any substance other than a food which is intended to "affect the structure or any function of the body of man" þ in other words, to produce pharmacological effects þ is a "drug" subject to FDA jurisdiction.
The release also admits that "Philip Morris employees have . . . stated that people smoke primarily for the pharmacological effects of nicotine."
Thus, in addition to the key admission that nicotine creates pharmacological effects in smokers, the tobacco giant also conceded that such effect are a primary reason why people smoke.
This, the U.S. Court of Appeals held in a law suit brought by Action on Smoking and Health (ASH), may by itself satisfy the requirements for the classification of a substance as a "drug."
The PM release argues that such pharmacological effects, by themselves, shouldn't make substances subject to FDA jurisdiction, citing the pharmacological effects of caffeine and sugar.
But, says Banzhaf, caffeine is a "drug" when it is sold in tablets.
Moreover, caffeine þ like sugar þ is already within the jurisdiction of the FDA when it is found in foods, either naturally as in the case of coffee or tea, or when added as an additional ingredient to foods such as soft drinks.
Banzhaf also noted that the legal test for a "drug" depends upon the intent of the manufacturer's executives, not obscure chemists who work for them.
--------------------------------------------------------------------------------
EXCERPTS FROM FREEDMAN, TOBACCO: PHILIP MORRIS MEMO LIKENS NICOTINE TO COCAINE, WALL STREET JOURNAL, DEC. 8, 1995
Tobacco-company executives have long maintained that people smoke because they enjoy the taste and sensation. The industry publicly rejects the allegation that cigarettes function primarily as nicotine dispensers. But with unprecedented bluntness, an internal Philip Morris Cos. draft report freely acknowledges what critics have charged: Cigarettes are a "nicotine delivery system"; the main reason people smoke is to get nicotine into their bodies; and nicotine is chemically "similar" to such drugs as cocaine. The confidential internal document, which is undated but cites data from as recently as 1992, is a proposal for a "safer" cigarette with the code name Table. Steven Parrish, Philip Morris's top spokesman, says the document was written by a nonscientist and doesn't reflect the views of the company on nicotine or smoking. An individual at the company further explains that the task force working on Project Table disbanded in late 1992 after making a presentation to senior management.
In congressional testimony and other public statements, top cigarette-company executives have denied the FDA's allegation about cigarettes' chief purpose. The Philip Morris document, however, appears to lend some support to the claim by asserting that "the primary reason" people smoke is "to deliver nicotine into their bodies."
The 15-page Philip Morris draft report likens nicotine to a drug in both its composition and its effects on the brain. In calling nicotine a "similar, organic chemical" to the drugs cocaine, morphine, quinine and atropine, the document states that "while each of these substances can be used to affect human physiology, nicotine has a particularly broad range of influence."
Nicotine travels to the brain about eight to 10 seconds after a smoker inhales and "alters the state of the smoker," according to the Philip Morris draft report. Nicotine does this, it says, by becoming both a neurotransmitter, a chemical substance that transmits signals from one nerve cell to another, and a stimulant. "Nicotine mimics the body's most crucial neurotransmitter, acetycholine (ACH), which controls heart rate and message sending within the brain," the draft report states.
In this way, the document continues, "nicotine is used to change psychological states leading to enhanced mental performance and relaxation." The draft report adds that "a little nicotine seems to stimulate, while a lot sedates a person. A smoker learns to control the delivery of nicotine through the smoking technique to create the desired mood state."
Mr. Parrish, the Philip Morris spokesman, responds, "We have acknowledged in public documents that nicotine, like many, many other things, has pharmacological effects, but that doesn't mean that cigarette smoking is addictive." He adds, "This document nowhere says that nicotine produces addiction -- the document doesn't even discuss addiction."
Cigarette-company executives have described the role of nicotine much differently than does the Philip Morris document. Last April, for instance, William Campbell, then head of Philip Morris's tobacco unit, testified at a congressional hearing that "nicotine contributes to the taste of cigarettes and the pleasures of smoking. The presence of nicotine, however, does not make cigarettes a drug or smoking an addiction." The document describes Philip Morris's own proposed entry as a "nicotine delivery device." And it lumps cigarettes with products that have no other function than to dispense nicotine: "Nicotine delivery devices range from snuff, chewing tobacco, cigars, pipes and conventional cigarettes to unique smoking articles, chewing gum, patches, aerosol sprays and inhalers." This statement is potentially useful to the FDA in its effort to prove that tobacco companies are in the drug business, health officials say.
--------------------------------------------------------------------------------
EXCERPTS FROM THE MEMO ITSELF
Different people smoke for different reasons. But the primary reason is to deliver nicotine into their bodies. Nicotine is an alkaloid derived from the tobacco plant. It is a physiologically active, nitrogen containing substance. Similar organic chemicals include nicotine, quinine, cocaine, atropine and morphine. While each of these substances can be used to affect human physiology, nicotine has a particularly broad range of influence.
During the smoking act, nicotine is inhaled into the lungs in smoke, enters the bloodstream and travels to the brain in about eight to ten seconds. The nicotine alters the state of the smoker by becoming a neurotransmitter and a stimulant. Nicotine mimics the body's most important neurotransmitter, acetycholine (ACH), which controls heart rate and message sending within the brain. The nicotine is used to change physiological states leading to enhanced mental performance and relaxation. A little nicotine seems to stimulate, while a lot sedates a person. A smoker learns to control the delivery of nicotine through the smoking technique to create the desired mood state. In general, the smoker uses nicotine's control to moderate a mood, arousing attention in boring situations and calming anxiety in tense situations. Smoking enhances the smoker's mental performance and reduces anxiety in a sensorially pleasurable form.
In its broadest sense, the cigarette is a pleasure product. It alters mood states just like the caffeine, alcohol and sugar in other Philip Morris products that affect human physiology and psychology. As with nicotine, these substances become part of an individual's life style and are used as coping mechanisms to help adjust to the environment.
Nicotine delivery devices range from snuff, chewing tobacco, cigars, pipes and conventional cigarettes to unique smoking articles, chewing gum, patches, aerosol sprays and inhalers. The manufacturers of these products also vary considerably in type, size, areas of expertise and marketing approach. The chart below summarizes the major competitors, their area of focus and their target market.
The pharmaceutical companies, on the other hand, are pursuing substitute nicotine delivery devices in a range of formats -- from patches to pills to inhalers. Their stated motivation is smoking cessation. The drug company devices generally lack the ritual of the smoking act and its sensual pleasures, but they do deliver nicotine in its most basic form.
Philip Morris has chosen to pursue a nicotine delivery device that, like RJR's Premier, continues the cigarette tradition of sucking on a cylindrical mouthpiece to inhale flavorings and nicotine form a tobacco based product.
NOTE: The entire document may be downloaded from the Wall Street Journal's Money & Investing Update at:
http://update.wsj.com











![[H³]](/images/user/11948_3861384.jpg)
